• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

威尔姆斯肿瘤抑制基因WT1:从结构到肾脏病理生理特征

Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.

作者信息

Mrowka C, Schedl A

机构信息

Max Delbrück Center for Molecular Medicine, Humboldt University of Berlin, Berlin-Buch, Germany.

出版信息

J Am Soc Nephrol. 2000 Nov;11 Suppl 16:S106-15.

PMID:11065340
Abstract

Normal development of the kidney is a highly complex process that requires precise orchestration of proliferation, differentiation, and apoptosis. In the past few years, a number of genes that regulate these processes, and hence play pivotal roles in kidney development, have been identified. The Wilms' tumor suppressor gene WT1 has been shown to be one of these essential regulators of kidney development, and mutations in this gene result in the formation of tumors and developmental abnormalities such as the Denys-Drash and Frasier syndromes. A fascinating aspect of the WT1 gene is the multitude of isoforms produced from its genomic locus. In this review, our current understanding of the structural features of WT1, how they modulate the transcriptional and post-transcriptional activities of the protein, and how mutations affecting individual isoforms can lead to diseased kidneys is summarized. In addition, results from transgenic experiments, which have yielded important findings regarding the function of WT1 in vivo, are discussed. Finally, data on the unusual feature of RNA editing of WT1 transcripts are presented, and the relevance of RNA editing for the normal functioning of the WT1 protein in the kidney is discussed.

摘要

肾脏的正常发育是一个高度复杂的过程,需要精确协调细胞增殖、分化和凋亡。在过去几年中,已经鉴定出许多调节这些过程并因此在肾脏发育中起关键作用的基因。肾母细胞瘤抑制基因WT1已被证明是肾脏发育的这些重要调节因子之一,该基因的突变会导致肿瘤形成和发育异常,如Denys-Drash综合征和Frasier综合征。WT1基因的一个引人入胜的方面是其基因组位点产生的多种异构体。在这篇综述中,总结了我们目前对WT1结构特征的理解,它们如何调节蛋白质的转录和转录后活性,以及影响单个异构体的突变如何导致肾脏疾病。此外,还讨论了转基因实验的结果,这些实验产生了关于WT1在体内功能的重要发现。最后,展示了关于WT1转录本RNA编辑异常特征的数据,并讨论了RNA编辑与WT1蛋白在肾脏中正常功能的相关性。

相似文献

1
Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.威尔姆斯肿瘤抑制基因WT1:从结构到肾脏病理生理特征
J Am Soc Nephrol. 2000 Nov;11 Suppl 16:S106-15.
2
Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.迪尼-德拉斯综合征点突变对肾母细胞瘤抑制蛋白WT1的DNA结合活性的影响。
Biochemistry. 1996 Sep 17;35(37):12070-6. doi: 10.1021/bi960758o.
3
The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.肾母细胞瘤基因WT1可调控参与性别决定和分化的基因:SRY、苗勒管抑制物质和雄激素受体。
Clin Cancer Res. 1997 Dec;3(12 Pt 2):2571-80.
4
Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.对来自冷冻人肾和肾母细胞瘤的天然WT1蛋白的分析。
Oncogene. 1999 Apr 15;18(15):2533-6. doi: 10.1038/sj.onc.1202618.
5
Wilms tumor and the WT1 gene.肾母细胞瘤与WT1基因。
Exp Cell Res. 2001 Mar 10;264(1):74-99. doi: 10.1006/excr.2000.5131.
6
Imbalanced expression of functionally different WT1 isoforms may contribute to sporadic unilateral Wilms' tumor.功能不同的WT1异构体表达失衡可能导致散发性单侧肾母细胞瘤。
Biochem Biophys Res Commun. 1999 Jan 8;254(1):197-9. doi: 10.1006/bbrc.1998.9897.
7
Expression of WT1 protein in fetal kidneys and Wilms tumors.WT1蛋白在胎儿肾脏和肾母细胞瘤中的表达。
Lab Invest. 1994 Oct;71(4):472-9.
8
Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.威尔姆斯瘤基因WT1的差异剪接外显子5可改变基因功能。
Anticancer Res. 1996 Mar-Apr;16(2):621-6.
9
Induction of p21 by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对p21的诱导作用。
Cancer Res. 1997 Apr 15;57(8):1429-34.
10
Pax-2, kidney development, and oncogenesis.Pax-2、肾脏发育与肿瘤发生
Med Pediatr Oncol. 1996 Nov;27(5):440-4. doi: 10.1002/(SICI)1096-911X(199611)27:5<440::AID-MPO9>3.0.CO;2-M.

引用本文的文献

1
Comprehensive prognostic gene identification and functional characterization of GRAMD1A in Wilms tumor: development of risk prediction models and therapeutic implications.肾母细胞瘤中GRAMD1A的综合预后基因鉴定及功能表征:风险预测模型的建立及治疗意义
Front Oncol. 2024 Nov 26;14:1501718. doi: 10.3389/fonc.2024.1501718. eCollection 2024.
2
Pathophysiology of Congenital Anomalies of the Kidney and Urinary Tract: A Comprehensive Review.先天性肾和尿路畸形的病理生理学:全面综述。
Cells. 2024 Nov 11;13(22):1866. doi: 10.3390/cells13221866.
3
Upregulation of HOXA3 by isoform-specific Wilms tumour 1 drives chemotherapy resistance in acute myeloid leukaemia.
同源盒 A3 基因通过 Wilms 瘤 1 异构体特异性上调导致急性髓系白血病化疗耐药。
Br J Haematol. 2024 Jul;205(1):207-219. doi: 10.1111/bjh.19563. Epub 2024 Jun 12.
4
Pediatric Kidney Transplantation: Cancer and Cancer Risk.小儿肾移植:癌症与癌症风险
Semin Nephrol. 2024 Jan;44(1):151501. doi: 10.1016/j.semnephrol.2024.151501. Epub 2024 Apr 4.
5
Benchmarking splice variant prediction algorithms using massively parallel splicing assays.基于大规模并行拼接分析的剪接变异预测算法的基准测试。
Genome Biol. 2023 Dec 21;24(1):294. doi: 10.1186/s13059-023-03144-z.
6
High-Throughput Splicing Assays Identify Known and Novel Exon 9 Variants in Nephrotic Syndrome.高通量剪接分析鉴定出肾病综合征中已知和新型的外显子9变体。
Kidney Int Rep. 2023 Aug 5;8(10):2117-2125. doi: 10.1016/j.ekir.2023.07.033. eCollection 2023 Oct.
7
Genotype-phenotype correlation of mutation-related nephropathy in Chinese children.中国儿童突变相关性肾病的基因型-表型相关性
Front Pediatr. 2023 Jul 27;11:1192021. doi: 10.3389/fped.2023.1192021. eCollection 2023.
8
Benchmarking splice variant prediction algorithms using massively parallel splicing assays.使用大规模平行剪接分析对剪接变体预测算法进行基准测试。
bioRxiv. 2023 May 7:2023.05.04.539398. doi: 10.1101/2023.05.04.539398.
9
A case of Potter sequence with WT1 mutation.WT1 基因突变相关 Potter 序列综合征 1 例
CEN Case Rep. 2023 May;12(2):184-188. doi: 10.1007/s13730-022-00742-x. Epub 2022 Oct 13.
10
The genetics of glaucoma: Disease associations, personalised risk assessment and therapeutic opportunities-A review.青光眼的遗传学:疾病关联、个性化风险评估和治疗机会——综述。
Clin Exp Ophthalmol. 2022 Mar;50(2):143-162. doi: 10.1111/ceo.14035. Epub 2022 Jan 17.